Search engine for discovering works of Art, research articles, and books related to Art and Culture
Javascript must be enabled to continue!
Cardiovascular Safety of Anti-Sclerostin Therapy in Chronic Kidney Disease
View through CrossRef
The significance of sclerostin for bone and cardiovascular health in patients with chronic kidney disease (CKD) is complex and incompletely understood. Experimental evidence suggests that anti-sclerostin therapy shows diminished efficacy on bone in the setting of CKD. Limited clinical evidence suggests that the osteoanabolic and anti-resorptive activity is attenuated, but hypocalcemia is more prevalent in patients with advanced CKD (eGFR < 30 mL/min) treated with anti-sclerostin (romosozumab) therapy as compared to patients without kidney disease. Furthermore, sclerostin is prominently expressed in uremic arteries. Whether the inhibition of sclerostin has adverse effects on cardiovascular health in CKD is currently unknown. This review summarizes the current understanding of the physiology and pathophysiology of sclerostin in CKD, with a focus on the cardiovascular safety of anti-sclerostin therapy in patients with or without CKD.
Title: Cardiovascular Safety of Anti-Sclerostin Therapy in Chronic Kidney Disease
Description:
The significance of sclerostin for bone and cardiovascular health in patients with chronic kidney disease (CKD) is complex and incompletely understood.
Experimental evidence suggests that anti-sclerostin therapy shows diminished efficacy on bone in the setting of CKD.
Limited clinical evidence suggests that the osteoanabolic and anti-resorptive activity is attenuated, but hypocalcemia is more prevalent in patients with advanced CKD (eGFR < 30 mL/min) treated with anti-sclerostin (romosozumab) therapy as compared to patients without kidney disease.
Furthermore, sclerostin is prominently expressed in uremic arteries.
Whether the inhibition of sclerostin has adverse effects on cardiovascular health in CKD is currently unknown.
This review summarizes the current understanding of the physiology and pathophysiology of sclerostin in CKD, with a focus on the cardiovascular safety of anti-sclerostin therapy in patients with or without CKD.
Related Results
Bone Sclerostin and Dickkopf-related protein-1 are positively correlated with bone mineral density, bone microarchitecture, and bone strength in postmenopausal osteoporosis
Bone Sclerostin and Dickkopf-related protein-1 are positively correlated with bone mineral density, bone microarchitecture, and bone strength in postmenopausal osteoporosis
Abstract
Background
Wnt-catenin signaling antagonists sclerostin and dickkopf-related protein-1 (Dkk-1) inhibit bone formation and are involved in t...
Relationship between sclerostin and coronary tortuosity in postmenopausal females with non-obstructive coronary artery disease
Relationship between sclerostin and coronary tortuosity in postmenopausal females with non-obstructive coronary artery disease
Abstract
Background
Coronary tortuosity (CT) is commonly encountered in postmenopausal females and is usually present without ob...
P1680MINERAL METABOLISM CHANGES AFTER RENAL TRANSPLANTATION
P1680MINERAL METABOLISM CHANGES AFTER RENAL TRANSPLANTATION
Abstract
Background and Aims
Successful renal transplant restores many physiologic abnormalities, including improvement of chron...
MicroRNA-204 may predict the renal function in patients with chronic kidney disease
MicroRNA-204 may predict the renal function in patients with chronic kidney disease
Background:
Chronic kidney disease significantly affects human health by loss of excretory kidney function. MicroRNAs have potential predictive and therapeutic signific...
MO121ASSOCIATION BETWEEN BONE MINERAL DENSITY, BODY COMPOSITION AND SERUM SCLEROSTIN IN MALE STONE-FORMERS
MO121ASSOCIATION BETWEEN BONE MINERAL DENSITY, BODY COMPOSITION AND SERUM SCLEROSTIN IN MALE STONE-FORMERS
Abstract
Background and Aims
Reduced bone mineral density (BMD) has been observed in stone-formers (SF). Although obesity is con...
Applying Logistic Regression to Predict Diabetic Nephropathy Based on Some Clinical and Paraclinical Characteristics of Type 2 Diabetic Patients
Applying Logistic Regression to Predict Diabetic Nephropathy Based on Some Clinical and Paraclinical Characteristics of Type 2 Diabetic Patients
Today, the incidence of type 2 diabetes mellitus is increasing rapidly on global. This disease is shown with many complications that significantly affect public health. One of them...
The Impact of IL28B Gene Polymorphisms on Drug Responses
The Impact of IL28B Gene Polymorphisms on Drug Responses
To achieve high therapeutic efficacy in the patient, information on pharmacokinetics, pharmacodynamics, and pharmacogenetics is required. With the development of science and techno...
Serum Sclerostin as a Marker of Microvascular and Macrovascular Complications among Children and Adolescents with Type 1 Diabetes Mellitus
Serum Sclerostin as a Marker of Microvascular and Macrovascular Complications among Children and Adolescents with Type 1 Diabetes Mellitus
Abstract
Background: Chronically uncontrolled diabetes mellitus (DM) is linked to long-term micro and macrovascular adverse outcomes, through speeding up atherosclerosis an...